Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injection

Movement Disorders

Volumn 16, Issue 4, 2001, Pages 779-782

  Cho, JiWhan ^a   Chu, Kon ^a   Jeon, Beom S ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ESSENTIAL TREMOR; FACE MUSCLE; HUMAN; MALE; MUSCLE CONTRACTION; NECK MUSCLE; PALATE DISEASE; PRIORITY JOURNAL; SKELETAL MUSCLE; TEMPORALIS MUSCLE; TONGUE; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; ELECTROMYOGRAPHY; ESSENTIAL TREMOR; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; PALATE, SOFT; TREATMENT OUTCOME;

EID: 0035412940     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1132     Document Type: Article

References (26)

1. Deuschl, G, Mischke G, Schenck E, Schulte-Mönting J, Lücking CH. Symptomatic and essential rhythmic palatal myoclonus. Brain 1990;113:1645-1672.
2. Deuschl G, Toro C, Valls-Solé J, Zeffiro T, Zee DS, Hallett M. Symptomatic and essential palatal tremor. Clinical, physiological and MRI analysis. Brain 1994;117:775-788.
3. Deuschl G, Löhle E, Heinen F, Lücking C. Ear click in palatal tremor: its origin and treatment with botulinum toxin. Neurology 1991;41:1677-1679.
4. Deuschl G, Toro C, Hallett M. Symptomatic and essential palatal tremor. 2 Difference of palatal movements. Mov Disord 1994;9: 676-678.
5. Bryce GE, Morrison MD. Botulinum toxin treatment of essential palatal myoclonus tinitus. J Otolaryngol 1998;27:213-216.
6. Jamieson DRS, Mann C, O'Reilly B, Thomas AM. Ear clicks in palatal tremor caused by activity of the levator veli palatini. Neurology 1996;46:1168-1169.
7. Vieregge P, Klein C, Gehrking E, Körke D, Kömpf D. The diagnosis of "essential palatal tremor". Neurology 1997;49:248-249.
8. Klein C, Gehrking E, Vieregge P. Voluntary palatal tremor in two siblings. Mov Disord 1998;13:545-548.
9. Jacobs L, Newman RP, Bozian D. Disappearing palatal myoclonus. Neurology 1981;31:748-51.
10. Leventon G, Man A, Floru S. Isolated psychogenic palatal myoclonus as a cause of objective tinnitus. Acta Otolaryngol 1968;65: 391-396.
11. Politzer A. Klonischer krampf der muskeln der tuba eustachii. Wiener Medizinische Presse 1870;11:561-562.
12. Varney SM, Demetroulakos JL, Fletcher MH, McQueen WJ, Hamilton MK. Palatal myoclonus: treatment with Clostridium botulinum toxin injection. Otolaryngol Head Neck Surg 1996;114:317-320.
13. Saeed SR, Brookes GB. The use of clostridium botulinum toxin in palatal myoclonus. A preliminary report. J Laryngol Otol 1993; 107:208-210.
14. Götze A Jr. Uber objektive Ohrgeräusche myoklonischer Genese. Z Laryngol Otol ihre Grenzgeb 1957;336:394-403.
15. Gupta OP, Samant HC, Katiyar BC. Velo-pharyngo-laryngeal myoclonia with objective tinnitus. Eye Ear Nose Throat Mon 1972; 51:306-309.
16. Kwee HL, Struben WH. Tinnitus and myoclonus. J Laryngol Otol 1972;86:237-241.
17. Montecucco C, Schiavo G. Tetanus and botulism neurotoxins: a new group of zinc proteases. Trend Bio Sci 1993;18:324-327.
18. Davis D, Jabbari B. Significant improvement of stiff person syndrome after paraspinal injection of botulinum toxin A. Mov Disord 1993;8:371-373.
19. Nix WA, Butler IJ, Roontga S, Gutmann L, Hopf HC. Persistent unilateral tibialis anterior muscle hypertrophy with complex repetitive discharges and myalgia. Report of two unique cases and responses to botulinum toxin. Neurology 1992;42:602-606.
20. Giladi N, Meer J, Kidan C, Greenberg E, Gross B, Honigman S. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology. Israel J Med Sci 1994;30:816-819.
21. Jankovic J, Schwart K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40:277-280.
22. Elston JS, Russell RW. Effects of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J 1985;290:1857-1859.
23. Ross MH, Charness ME, Sudarsky L, Logigian EL. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles. Muscle Nerve 1997;20:593-598.
24. Eleopra R, Tugnoli V, Caniatti L, De Grandis D. Botulinum toxin treatment in the facial muscles of humans: Evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 1996;46:1158-1160.
25. Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread of Botulinum toxin through muscle fascia. Laryngoscope 1991;101:960-964.
26. Giladi N. The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 1997;152:132-135.